About Kissei Pharmaceutical
Kissei Pharmaceutical is a company based in Matsumoto (Japan) founded in 1946.. The company has 1,780 employees as of March 31, 2024. Kissei Pharmaceutical operates in a competitive market with competitors including Amyris, Avidity Biosciences, Arbor Biotechnologies, Univercells and Sutro Biopharma, among others.
- Headquarter Matsumoto, Japan
- Employees 1780 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Kissei Pharmaceutical Co., Ltd.
-
Annual Revenue
$562.79 M (USD)16.87as on Mar 31, 2024
-
Net Profit
$76.2 M (USD)7.17as on Mar 31, 2024
-
EBITDA
$67.35 M (USD)27.8as on Mar 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
1780
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Kissei Pharmaceutical
Kissei Pharmaceutical is a publicly listed company on the TSE with ticker symbol 4547 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Kissei Pharmaceutical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Kissei Pharmaceutical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Kissei Pharmaceutical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Kissei Pharmaceutical Comparisons
Competitors of Kissei Pharmaceutical
Kissei Pharmaceutical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Avidity Biosciences, Arbor Biotechnologies, Univercells and Sutro Biopharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of renewable products for industrial solutions
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Genomic technologies and drug discovery platforms are provided.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Kissei Pharmaceutical
Frequently Asked Questions about Kissei Pharmaceutical
When was Kissei Pharmaceutical founded?
Kissei Pharmaceutical was founded in 1946.
Where is Kissei Pharmaceutical located?
Kissei Pharmaceutical is headquartered in Matsumoto, Japan. It is registered at Matsumoto, Nagano, Japan.
How many employees does Kissei Pharmaceutical have?
As of Mar 31, 2024, the latest employee count at Kissei Pharmaceutical is 1,780.
What is the annual revenue of Kissei Pharmaceutical?
Annual revenue of Kissei Pharmaceutical is $562.79M as on Mar 31, 2024.
What does Kissei Pharmaceutical do?
Kissei Pharmaceutical was founded in 1946 in Matsumoto, Japan, and operates within the pharmaceutical sector. Focus is placed on developing treatments for renal diseases and anemia associated with urology conditions. The lead product, JR-131, an injectable form of re-engineered erythropoietin, has completed phase III clinical trials for anemia management. Operations emphasize research and clinical advancement in these therapeutic areas.
Who are the top competitors of Kissei Pharmaceutical?
Kissei Pharmaceutical's top competitors include Sutro Biopharma, Avidity Biosciences and Arbor Biotechnologies.
Is Kissei Pharmaceutical publicly traded?
Yes, Kissei Pharmaceutical is publicly traded on TSE under the ticker symbol 4547.
What is Kissei Pharmaceutical's ticker symbol?
The ticker symbol of Kissei Pharmaceutical is 4547 on TSE.